Sanofi's Infilbray wins first approval for neurological symptoms of Gaucher
Sanofi won approval Wednesday for Infilbray, the first drug in the US to treat the neurological symptoms of a rare genetic disorder called Gaucher disease. Infilbray, also known as venglustat, crosses the blood-brain barrier to ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Sanofi gains FDA clearance for Gaucher disease pill biopharmadive.com